Cipla to re-start supplying anti-HIV drugs to Naco: Report

13 Jan 2015 Evaluate

Cipla is reportedly planning to re-start supplying anti-HIV drugs to the National Aids Control Organisation (Naco) in the next two months.

The Mumbai-based drug company had, during the second half of last year, stopped bidding for Naco tenders. The company had participated in the Naco’s paediatric tenders, which were being evaluated.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×